RPS6KA6 Knockout HAP1 Cell Line

The choice depends on whether you are studying RPS6KA6 (RSK4)'s role as the least-characterized member of the p90 ribosomal S6 kinase family or its emerging functions in cancer biology and drug resistance. The Knockout line is appropriate for asking whether RSK4 is required for substrate phosphorylation in contexts where the other RSK family members (RSK1-3) may not fully compensate. Overexpression is useful for studying RSK4 in cancer contexts where it has been reported as a tumor suppressor (in some tumors) or pro-tumor factor (in others) depending on cellular context. Important consideration: RSK1 (RPS6KA1), RSK2 (RPS6KA3), and RSK3 (RPS6KA2) share substantial functional overlap with RSK4 — single RSK4 knockout in HAP1 may show modest phenotypes if other RSK paralogs compensate. The EDITGENE Knockout in HAP1 provides a clean genetic background for RSK4-specific functional studies. Rescue with wild-type or kinase-dead RSK4 is the standard specificity control, and is critical for testing RSK family inhibitors (BI-D1870, LJI308) for RSK4-specific versus pan-RSK effects.

Primary applications: • RSK substrate phosphorylation: phospho-S6 (S235/236), phospho-CREB (S133), and other RSK family substrate analysis to assess RSK4-dependent phosphorylation. • RSK family inhibitor specificity: critical genetic control for BI-D1870, LJI308, FMK-MEA, and other RSK-targeting compounds to distinguish RSK4-specific effects. • Cancer phenotype assays: proliferation, apoptosis sensitivity, and chemoresistance studies given RSK4's context-dependent tumor suppressor/promoter functions. • Paralog studies: RSK1/RSK2/RSK3 expression analysis to interpret RSK4-specific phenotypes. EDITGENE recommends this model for researchers investigating RSK family kinase biology and RSK4-specific functions in cancer biology.

Yes. RSK4 rescue experiments require attention to the dual-kinase architecture characteristic of RSK family: • Construct design: use a codon-modified RPS6KA6 sequence with a small C-terminal tag (FLAG, HA). RSK4 has N-terminal kinase domain (NTKD, AGC family) and C-terminal kinase domain (CTKD, CAMK family) — preserve both. • Kinase-dead rescue: K447A mutation in the NTKD (substrate-phosphorylating domain) abolishes catalytic activity and is the standard specificity control. • Paralog considerations: RSK1/RSK2/RSK3 expression analysis aids interpretation of RSK4-specific rescue effects. • Functional readout: rescue should restore RSK substrate phosphorylation and downstream gene expression patterns specific to RSK4. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.